1. Biocat BioWin Euromediag LifeScience Klaster Krakow
WHERE SCIENCE MEETS BUSINESS
The organization that coordinates, dynamizes and pro- BioWin is the health competitiveness cluster of Wallonia Stimulating synergy in the medical diagnostics sector and THE NETWORK OF OVER 70 PARTNERS
motes biotechnology, biomedicine and medical technology (Belgium). generating intellectual and industry-wide tropism in the REPRESENTING 6 INTEREST GROUPS
sector in Catalonia. south of France. ÷ EDU – 5 universities and high schools
BIOWIN’s OBJECTIVES
÷ R&D – 5 national institutes
Biocat’s mission is helping to create the right environment ÷ to create a new culture of partnership favourable to DIAGNOSTICS SCIENCE AND INDUSTRY
÷ BioF – 30 bio & lifescience dedicated businesses
to add value to research in Catalonia, through knowledge innovation ÷ Supported by Eurobiomed
÷ Med – 11 hospitals and health care organizations
transfer, in order to consolidate biotechnology and ÷ to grow a human capital of excellence ÷ Comprised of more than 70 small, medium and large
÷ Biz – 16 business support & business consulting
biomedicine as a major economic sector and strengthen ÷ to develop collective infrastructures and platforms companies involved with diagnostics (such as Bio-Rad,
÷ GOV – 3 local government bodies
its role in society. ÷ to promote internationally the strengths of Wallonia Horiba Medical, Cisbio, Ipsogen, ThermoFisher Scientific,
(especially its SMEs) in the health domains I2A, Alphabio, etc.), as well as 45 research institutes MEDICAL DIAGNOSTICS WORKING GROUP
Biocat’s strategy focuses in consolidating the BioRegion
The network of 27 organizations involved in:
of Catalonia as a cluster, promoting business competitive- WAL-DX ACTIONS AND MEDICAL R&D TOPICS
÷ Basic research and R&D (7 science institutes and
ness, internationalization, training and talent and social WAL-Dx is the permanent working group of BioWin made of ÷ Formalizing a strong medical diagnostics network in the
universities + 6 business organizations)
perception of biotechnology. members active in the area of in vitro Diagnostics south of France
÷ Services ( 7 hospitals, 3 clinical hospitals, 3 business
÷ Around 20 companies (mainly innovative high ÷ Stimulating international partnerships and links with other
THE BIOREGION OF CATALONIA organizations)
potential SMEs ) medical diagnostics bioclusters (EDC-Alliance, Israel,
SCIENCE AND INDUSTRY RELATED ÷ Promotion and training (Modern Diagnostics Academy)
÷ 3 universities academia India, Canada)
TO IN VITRO-DIAGNOSTICS
÷ 4 non-university research institutes ÷ Performing strategic analyses of the medical diagnostics MAJOR R&D-TOPICS
÷ More than 50 research groups
field and competitiveness ÷ Molecular diagnostics
÷ About 50 companies EXPERTISE, RESOURCES AND
÷ Developing collaborative projects, in particular related to ÷ Imaging
INNOVATION CAPACITIES
MAJOR TOPICS medical R&D topics covered by Eurobiomed: infectious, ÷ Biomarkers
÷ Science , technology and education
÷ Molecular diagnostic kits and techniques tropical, and emerging pathologies, rare and orphan ÷ Bioinformatics
÷ Biomarkers identification and industrialisation
÷ Genetic diagnostic tools diseases, immunology, aging, neurology and handicaps
÷ Diagnostic tools development OTHER
÷ Research, manufacturing and distribution of clinical ÷ Contributing to the creation and participation of Master’s
÷ Signal analysis ÷ Clinical research (broad indications base)
diagnostics devices and reagents degrees and professional or vocational training dedicated
÷ E-management of signal data ÷ BioBanking
÷ Nanobiosensors for early diagnosis to medical diagnostics
÷ Design and production ÷ Screening program management systems /
÷ Molecular medicine; molecular basis of omic disease ÷ Attracting investment, companies, and new jobs to the
÷ Biologistics multidimensional medical data analysis
region in order to create a strong diagnostic center
÷ Attracting investments, companies and job creations in the
BioWin / WAL-Dx region to build up a “diagnostic bay”
Thierry Leclipteux · Chairman of WAL-Dx LifeScience Klaster Krakow
Biocat. Point Centre – Avenue Georges Lemaître, 19 Medical Diagnostics Working Group
Carlos Lurigados · Innovation Project Director 6041 Gosselies · Belgium Euromediag Bobrzynskiego 14 · 30-348 Krakow · Poland
Phone +34 93 3103389 · clurigados@biocat.cat th.leclipteux@corisbio.com · contact@biowin.org Pierre Vidal · Phone +33 760 670034 Phone +48 12 2974605 · Fax +48 12 2974646
www.biocat.cat www.biowin.org pierre.vidal@eurobiomed.org · www.euromediag.org mediag@lifescience.pl · www.lifescience.pl
Barcelona / Catalonia Gosselies / Belgium Montpellier / France Krakow / Poland
11065_EDCA_Flyer_02.indd 1-5 24.06.11 10:50

2. Nexxus Scotland Oxfordshire Bioscience Network Uppsala BIO Zentrum für Molekulare Diagnostik European Diagnostic Clusters Alliance
Creating Health, Promoting Wealth Diagnostic Science and Industry in und Bioanalytik (ZMDB) President: Franck Molina
Stockholm-Uppsala franck.molina@sysdiag.cnrs.fr
Phone +33 4 67166600 · Fax +33 4 67166601
SCIENCE AND INDUSTRY – HOME TO The network supports the interests of the UK bioindustry Uppsala BIO is a life science pathfinder, dedicated to The Berlin-Brandenburg Center for Molecular Diagnostics
÷ 15% of UK life science companies in Oxford and the South East of the UK. strengthen the life science sector’s long-term competitive- and Bioanalytics (ZMDB) is the platform for technology
÷ 150 Medical Device/Diagnostic companies ness. We work in close collaboration with industry, aca- transfer and supports cooperations between science, clinics
OBN: a not for profit biosciences business network
÷ 60 Pharma Services companies demia, healthcare and society. and industry.
established 12 years ago.
÷ 57 university and research facilities with
ACTIVITIES FOR INNOVATIVE DIAGNOSTICS GERMANY`S CAPITAL REGION BERLIN-BRANDENBURG
11,000 research staff ACTIVITIES
÷ BIO-X - a catalyser taking research results to proof-of- – YOUR PARTNER FOR NEXT GENERATION IN VITRO-
÷ Networking events -BioTuesday
MAJOR R&D-TOPICS concept, answering needs formulated by industry and DIAGNOSTICS:
÷ Partnering – BioTrinity the UK’s largest biopartnering and
÷ Point of care detection of infectious diseases healthcare
investment conference SCIENCE AND INDUSTRY
÷ Multi-parametric detection technologies ÷ Innovation Akademiska - the University Hospital as
÷ Group purchasing scheme for members ÷ More than 80 small and medium enterprises
÷ Novel biomarkers for detection a testbed supporting SMEs product development in
÷ Fundraising advisory role ÷ About 30 research institutes
÷ Lab-on-Chip devices diagnostics and med-tech
÷ Non-core: information, training, seminars, breakfast
÷ Regenerative and Translational Medicine MAJOR R&D-TOPICS
meetings SCIENCE AND INDUSTRY
÷ Improved detection systems: sensor-actor-molecules and
CLINICAL RESEARCH ÷ 6 Universities and 3 University Hospitals, 67 companies
MEMBERS autonomous biosensors
÷ Easy access to clinical skills and excellence through with 1040 employees and a turnover of 425 MEUR (2010)
÷ Over 200 members across the UK ÷ Lab-on-Chip devices
Scottish Academic Health Sciences Collaboration ÷ The diagnostics industry in the region is active in all
÷ Medical Diagnostics companies are the fastest ÷ Microarray- and bead-technologies: genome-, proteome-
(SAHSC) links of the value chain, from product development to
growing category and glycan-based multiplex analytics
÷ Generation Scotland – a population based genetic production, marketing and sales
÷ Metabolomics platforms for new biomarker strategies
information bank
MAJOR R&D TOPICS
CLINICAL VALIDATION AND BIOBANKING
÷ Last BIO-X Call: Diagnostic tools and methods for
÷ Advanced biobanking infrastructure with access to
screening, prognosis, diagnosis, or monitoring of treatment
metabiobanking
Nexxus of malign tumours, autoimmune disorders and infectious
÷ Broad patient cohorts for any indications
Mr Graeme Boyle · Director diseases in humans
10 The Square · University Avenue ÷ Strong research areas: Protein science, Molecular tools,
Glasgow · G12 8QQ · Scotland · UK Materials science and nano technology The ZMDB is your interface to get access to
g.boyle@nexxusscotland.com Berlin-Brandenburg´s expertise in in vitro-Diagnostics
www.nexxusscotland.com Uppsala BIO and bioanalytics!
Dr Till Bachmann · COO Assoc Prof Erik Forsberg · Managing Director
Division of Pathway Medicine · University of Edinburgh OBN Ltd Phone +46 18 4770421 · erik.forsberg@uppsalabio.se Zentrum für Molekulare Diagnostik und Bioanalytik (ZMDB)
Chancellor‘s Building · 49 Little France Crescent Jon Rees www.uppsalabio.se Dr. Günter Peine · Director Management and Coordination
Edinburgh · EH16 4SB · Scotland · UK Suite L · 11 Park House · Milton Park Phadia AB TSB Innovationsagentur Berlin GmbH
till.bachmann@ed.ac.uk Abingdon · Oxfordshire · OX14 4RS · UK Per Matsson · CTO Fasanenstrasse 85 • Berlin • Germany
www.pathwaymedicine.ed.ac.uk Phone +44 845 5215222 · www.obn.org.uk Phone +46 18 165000 · per.matsson@phadia.com Phone +49 30 31862217 · hahne@zmdb.de · www.zmdb.de
Glasgow / Scotland Oxfordshire / United Kingdom Uppsala / Sweden Berlin-Brandenburg / Germany This publication was built by means of the states of Berlin and Brandenburg and co-financed
by the European Regional Development Fund (ERDF) of the European Union.
11065_EDCA_Flyer_02.indd 6-10 24.06.11 10:51